Glycemic and risk factor control in type 1 diabetes - Results from 13,612 patients in a national diabetes register

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Glycemic and risk factor control in type 1 diabetes - Results from 13,612 patients in a national diabetes register. / Eeg-Olofsson, Katarina; Cederholm, Jan; Nilsson, Peter; Gudbjornsdottir, Soffia; Eliasson, Bjorn.

I: Diabetes Care, Vol. 30, Nr. 3, 2007, s. 496-502.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

Eeg-Olofsson, Katarina ; Cederholm, Jan ; Nilsson, Peter ; Gudbjornsdottir, Soffia ; Eliasson, Bjorn. / Glycemic and risk factor control in type 1 diabetes - Results from 13,612 patients in a national diabetes register. I: Diabetes Care. 2007 ; Vol. 30, Nr. 3. s. 496-502.

RIS

TY - JOUR

T1 - Glycemic and risk factor control in type 1 diabetes - Results from 13,612 patients in a national diabetes register

AU - Eeg-Olofsson, Katarina

AU - Cederholm, Jan

AU - Nilsson, Peter

AU - Gudbjornsdottir, Soffia

AU - Eliasson, Bjorn

PY - 2007

Y1 - 2007

N2 - OBJECTIVE - This study was designed to investigate the clinical characteristics of a large type 1 diabetic population and to evaluate the degree of fulfillment of recently updated treatment goals. RESEARCH DESIGN AND METHODS - The Swedish National Diabetes Register was initiated in 1996 as a tool for quality assurance in diabetes care. A1C levels, treatment, and risk factors were analyzed in two cross-sectional samples of 9,424 patients in 1997 and 13,612 patients in 2004 and in a smaller longitudinal sample from 1997 to 2004. RESULTS - Mean A1C decreased from 8.2 +/- 1.3% in 1997 to 8.0 +/- 1.2% in 2004 (P < 0.001). The proportion of patients reaching A1C < 7.0% increased from 17.4 to 21.2% in 2004. A slow but significant improvement in blood pressure levels was seen, but only 61.3% reached the blood pressure goal of < 130/80 mmHg in 2004. Lipid control improved, and the use of lipid-lowering drugs increased. Among patients treated with lipid-lowering agents, 38% reached the goal of total cholesterol < 4.5 mmol/l, and 48% reached the goal of LDL cholesterol < 2.5 mmol/l. Successful long-term glycemic, and blood pressure control were both independently predicted by low BMI and the absence of microalbuminuria in 1997. CONCLUSIONS - In this large cohort of type 1 diabetic patients, there was a slow improvement in glycemic and risk factor control from 1997 to 2004, although the gap between the clinical results and current Swedish and American treatment goals is still unsatisfactory. It is crucial that additional measures be taken to improve risk factor control in type 1 diabetic patients.

AB - OBJECTIVE - This study was designed to investigate the clinical characteristics of a large type 1 diabetic population and to evaluate the degree of fulfillment of recently updated treatment goals. RESEARCH DESIGN AND METHODS - The Swedish National Diabetes Register was initiated in 1996 as a tool for quality assurance in diabetes care. A1C levels, treatment, and risk factors were analyzed in two cross-sectional samples of 9,424 patients in 1997 and 13,612 patients in 2004 and in a smaller longitudinal sample from 1997 to 2004. RESULTS - Mean A1C decreased from 8.2 +/- 1.3% in 1997 to 8.0 +/- 1.2% in 2004 (P < 0.001). The proportion of patients reaching A1C < 7.0% increased from 17.4 to 21.2% in 2004. A slow but significant improvement in blood pressure levels was seen, but only 61.3% reached the blood pressure goal of < 130/80 mmHg in 2004. Lipid control improved, and the use of lipid-lowering drugs increased. Among patients treated with lipid-lowering agents, 38% reached the goal of total cholesterol < 4.5 mmol/l, and 48% reached the goal of LDL cholesterol < 2.5 mmol/l. Successful long-term glycemic, and blood pressure control were both independently predicted by low BMI and the absence of microalbuminuria in 1997. CONCLUSIONS - In this large cohort of type 1 diabetic patients, there was a slow improvement in glycemic and risk factor control from 1997 to 2004, although the gap between the clinical results and current Swedish and American treatment goals is still unsatisfactory. It is crucial that additional measures be taken to improve risk factor control in type 1 diabetic patients.

U2 - 10.2337/dc06-1406

DO - 10.2337/dc06-1406

M3 - Article

VL - 30

SP - 496

EP - 502

JO - Diabetes Reviews

T2 - Diabetes Reviews

JF - Diabetes Reviews

SN - 1935-5548

IS - 3

ER -